GLOW BPC 157 10mg + GHK-CU 50mg + TB500 10mg

Researchers investigate multi-peptide interaction using GLOW peptide blend in controlled settings. Multi-peptide interaction research examines how different peptides behave when combined in systems. Laboratory teams explore structural stability of blended peptides under various experimental conditions. Structural stability refers to how well peptides maintain their molecular configurations together. Scientists study laboratory workflow efficiency using combined peptide formulations instead of separate units. Workflow efficiency means researchers can streamline experimental protocols with pre-blended compounds. These studies occur exclusively in research environments without clinical applications.

GLOW peptide blend is investigated in research settings for multi-compound peptide studies. Scientists have studied this combination within controlled laboratory environments using standardized protocols. The formulation is explored for experimental peptide interaction research in academic facilities. Researchers evaluate the blend under controlled conditions without therapeutic claims.

Store GLOW peptide blend in cool, dry, light-protected conditions. Recommended storage temperature ranges between 2-8°C for unopened vials. This product is intended for laboratory handling only by qualified research personnel. Qualified personnel possess training in multi-peptide reconstitution and handling methods. Avoid moisture exposure as humidity can compromise peptide stability and quality. Moisture refers to water vapor in air or direct liquid water contact. Avoid heat exposure above specified temperature ranges to preserve structural integrity. Structural integrity means peptides maintain their proper molecular configurations. Reconstituted solutions should follow established laboratory guidelines for peptide research protocols.

Each GLOW peptide blend batch undergoes comprehensive purity verification procedures. Purity verification confirms all three peptides meet quality specifications within the blend. Our processes ensure batch-to-batch consistency across all research supply orders. Internal quality assurance standards follow research-grade supply positioning for peptide formulations. Research-grade positioning indicates products meet specifications for scientific laboratory use. Testing protocols verify all peptides maintain structural integrity and purity levels. Every unit receives quality approval before distribution authorization. Documentation packages accompany each order for institutional tracking and compliance purposes.

• CAS: BPC-157: 137525-51-0 GHK-Cu: 49557-75-7 TB500: 885340-08-9
• Chemical Formula: GHK-Cu: C₁₄H₂4N₆O₄ BPC-₁₅₇: C₆₂H₉₈N₁₆O₂₂ TB₅₀₀: C₃₈H₆₈N₁₀O₁₄
• Molecular Weight: GHK-Cu: 340.38 g/mol BPC-157: 1419.535 g/mol TB-500(TB-4): 889.0 g/mol
• Peptide Sequence: GHK-Cu: Gly-His-Lys (GHK) BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser
• Synonyms: glow, bpc157, tb500, thymosin beta 4, tb4, ghkcu, BPC-157, TB-500(TB-4)
• Shelf life: 24 months from the manufacturing date.

GHK-Cu is a copper-binding peptide studied extensively in laboratory research settings. This tripeptide naturally binds to copper ions forming a complex structure. Tripeptide means a peptide containing exactly three amino acid units. Researchers investigate how copper-peptide complexes behave in experimental models. Scientists examine the structural properties of metal-binding peptides in controlled systems.

BPC-157 represents a synthetic peptide explored for structural research models in laboratories. This pentadecapeptide consists of 15 amino acids in a specific sequence. Pentadecapeptide refers to a peptide chain with exactly 15 amino acid residues. Laboratory teams study how this synthetic sequence maintains stability under various conditions. Research examines peptide behavior patterns in experimental frameworks.

TB500 functions as a peptide fragment researched in controlled laboratory environments. This synthetic compound is derived from a larger naturally occurring protein. Researchers study peptide fragments to understand simplified molecular interactions. Scientists investigate how this fragment behaves in laboratory-based experimental systems.

GLOW peptide blend delivers a triple-peptide research formulation combining three distinct compounds. Triple-peptide formulations provide multiple peptides in one vial for laboratory efficiency. Each component undergoes high-purity testing and comprehensive batch verification. Batch verification ensures every production run maintains consistent quality specifications. The blend is designed for controlled laboratory environments conducting multi-peptide interaction research. Secure packaging with discreet shipment protects peptide integrity during transit to research facilities across the United States.

Glow is a combination research formulation containing BPC-157 (10mg), GHK-Cu (50mg), and TB-500 (10mg) — three peptide compounds studied individually in preclinical models for their reported effects on tissue signalling, angiogenesis, and cytoskeletal regulation respectively. The combination format allows researchers to investigate potential additive or complementary effects of these compounds in the same experimental system.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide studied in preclinical models for growth factor pathway interactions and cytoprotective signalling. GHK-Cu (copper peptide Gly-His-Lys) is a naturally occurring plasma tripeptide complexed with copper(II), studied for its reported effects on gene expression, wound-associated signalling, and antioxidant pathway modulation. TB-500 is a synthetic fragment of Thymosin Beta-4, studied for actin sequestration, cellular migration, and angiogenic signalling in vitro.

The three peptides are co-lyophilised in a defined ratio and supplied as a single powder. Researchers should consult the certificate of analysis for mass confirmation of each component and prepare reconstitution conditions appropriate for all three peptides simultaneously — typically sterile aqueous buffer at neutral pH.

Research models relevant to this combination include wound healing assays (scratch assay, transwell migration), tube formation assays for angiogenic activity, cytoskeletal organisation studies, and gene expression profiling of tissue repair-associated genes in primary cell cultures. The combination design is suited to research investigating whether the three compounds act on convergent or independent signalling pathways.

No. The Glow combination as supplied by Elivena is for research use in controlled laboratory settings only. None of the components are approved for human administration, and this product is not supplied for any therapeutic or cosmetic human application.